Short cell-penetrating peptides: a model of interactions with gene promoter sites
Khavinson VKh, Tarnovskaya SI, Linkova NS, Pronyaeva VE, Shataeva LK, Yakutseni PP
Bulletin of Experimental Biology and Medicine (2013)
The Khavinson group's molecular-modeling proposal for how short peptides like Vilon (Lys-Glu) and Epitalon (Ala-Glu-Asp-Gly) could bind specific DNA promoter motifs — the in-silico mechanism that the rest of the Khavinson program leans on whenever it claims a four-residue peptide can drive selective gene expression.
This 2013 Bulletin of Experimental Biology and Medicine short report is the molecular-modeling foundation that the rest of the Khavinson short-peptide program rests on whenever it claims a four-residue peptide can drive selective gene expression. The previous entries in the Khavinson corpus document the effects — telomerase reactivation in fetal fibroblasts (Khavinson 2003), tumor suppression in mice (Anisimov-Khavinson 2001; Anisimov 2002), human-cohort mortality reduction (Khavinson + Morozov 2002 / 2003). This paper proposes the mechanism: that short peptides penetrate cells, enter the nucleus, and bind specific short DNA motifs in the promoter regions of named genes via molecular complementarity, regulating transcription directly.
The authors — Khavinson and Tarnovskaya at the I.P. Pavlov Institute of Physiology and the St. Petersburg Institute of Bioregulation and Gerontology — used molecular-mechanics modeling to characterize the interaction between two of the program's signature peptides (Vilon, Lys-Glu, KE; and Epitalon, Ala-Glu-Asp-Gly, AEDG) and two short DNA recognition motifs (GCAG and ATTTC) that the authors had previously localized in the promoter regions of four signal-molecule genes (CD5, IL-2, MMP2, Tram1). They reported analyses of hydrogen-bond counts, hydrophobic and electrostatic interactions, and DNA-peptide complex minimization energies, and built three-dimensional models of the peptide-DNA complexes intended to validate qualitative pairing predictions and quantify their binding strength.
The paper is the missing mechanistic link in the Khavinson corpus on this site: it is what the program offers when challenged on how a tetrapeptide could possibly produce the gene-expression and lifespan effects the rest of the literature claims.
The proposal is in-silico, not in-vitro. The paper is a molecular-mechanics modeling study with no cell-based or biochemical confirmation of (a) cellular uptake of the intact peptide, (b) nuclear localization, (c) actual DNA occupancy at the proposed motifs in living cells, or (d) the predicted gene-expression consequences of that occupancy in the same experimental system. The downstream Khavinson literature treats the in-silico binding as if it were demonstrated DNA occupancy, but this paper does not provide that evidence — it provides a complementarity model. The leap from "the computational binding energy is favorable" to "the peptide regulates this gene in vivo" is the load-bearing inference the program asks the reader to make.
The chosen DNA motifs are extremely short (4-5 base pairs: GCAG, ATTTC). Recognition sequences of this length appear hundreds of thousands of times across the human genome and are not in themselves specific. The paper localizes them within named gene-promoter regions, but a short peptide binding a four-base motif would, by sequence specificity alone, lack the selectivity needed to regulate only the named genes (CD5, IL-2, MMP2, Tram1) — additional structural or chromatin-contextual selectivity is asserted but not directly demonstrated for the peptides in question. This is the standard objection to short-motif gene-targeting proposals and is not idiosyncratic to this paper.
The authors and institute are the same St. Petersburg Institute of Bioregulation and Gerontology research group that developed and commercializes the Vilon and Epitalon peptides. This is the same conflict-of-interest landscape that applies to the rest of the Khavinson corpus; it does not invalidate the modeling work but is appropriate context.
The companion Linkova-and-Kuznik 2013 Advances in Gerontology paper applies the same modeling framework to Epitalon's claimed effect on interferon-gamma signaling during aging, and the program subsequently extended the framework to GDF11 (Glu-Asp-Arg / CCTGC; Ala-Glu-Asp-Gly / ATTTC; Lys-Glu / GCAG motifs in the GDF11 promoter region). The motif-pairing assignments are consistent across these later papers but inherit the same in-silico-only limitation.
07·Member discussion
No member discussion yet.
Member-only conversation lives here — cycle notes, practitioner commentary, pattern-matching. Be the first paying member to start the thread.